Found: 13
Select item for more details and to access through your institution.
Fragment-based drug discovery for disorders of the central nervous system: designing better drugs piece by piece.
- Published in:
- Frontiers in Chemistry, 2024, p. 1, doi. 10.3389/fchem.2024.1379518
- By:
- Publication type:
- Article
Structures, functions, and syntheses of glycero-glycophospholipids.
- Published in:
- Frontiers in Chemistry, 2024, p. 1, doi. 10.3389/fchem.2024.1353688
- By:
- Publication type:
- Article
Proteomics studies to investigate alterations in the tau interactome under conditions of elevated cellular O‐GlcNAcylation: Molecular and cell biology/tau.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.038276
- By:
- Publication type:
- Article
CDK12-mediated transcriptional regulation of noncanonical NF-κB components is essential for signaling.
- Published in:
- Science Signaling, 2018, v. 11, n. 541, p. 1, doi. 10.1126/scisignal.aam8216
- By:
- Publication type:
- Article
Antisense Oligonucleotide-Mediated Reduction of HDAC6 Does Not Reduce Tau Pathology in P301S Tau Transgenic Mice.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.624051
- By:
- Publication type:
- Article
Phosphorylated Dihydroceramides from Common Human Bacteria Are Recovered in Human Tissues.
- Published in:
- PLoS ONE, 2011, v. 6, n. 2, p. 1, doi. 10.1371/journal.pone.0016771
- By:
- Publication type:
- Article
Cover Feature: α‐Methylene‐β‐Lactone Scaffold for Developing Chemical Probes at the Two Ends of the Selectivity Spectrum (ChemBioChem 3/2021).
- Published in:
- ChemBioChem, 2021, v. 22, n. 3, p. 442, doi. 10.1002/cbic.202100010
- By:
- Publication type:
- Article
α‐Methylene‐β‐Lactone Scaffold for Developing Chemical Probes at the Two Ends of the Selectivity Spectrum.
- Published in:
- ChemBioChem, 2021, v. 22, n. 3, p. 505, doi. 10.1002/cbic.202000605
- By:
- Publication type:
- Article
Acute inhibition of the CNS-specific kinase TTBK1 significantly lowers tau phosphorylation at several disease relevant sites.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0228771
- By:
- Publication type:
- Article
Erratum to: A Stable Human-Cell System Overexpressing Cystic Fibrosis Transmembrane Conductance Regulator Recombinant Protein at the Cell Surface.
- Published in:
- 2015
- By:
- Publication type:
- Erratum
A Stable Human-Cell System Overexpressing Cystic Fibrosis Transmembrane Conductance Regulator Recombinant Protein at the Cell Surface.
- Published in:
- Molecular Biotechnology, 2015, v. 57, n. 5, p. 391, doi. 10.1007/s12033-014-9830-5
- By:
- Publication type:
- Article
Mechanisms of Regulation and Diverse Activities of Tau-Tubulin Kinase (TTBK) Isoforms.
- Published in:
- Cellular & Molecular Neurobiology, 2021, v. 41, n. 4, p. 669, doi. 10.1007/s10571-020-00875-6
- By:
- Publication type:
- Article
Measurement and utilization of the proteomic reactivity by mass spectrometry.
- Published in:
- Mass Spectrometry Reviews, 2024, v. 43, n. 1, p. 166, doi. 10.1002/mas.21837
- By:
- Publication type:
- Article